Evaluation of the efficacy of the injection of botulinum toxin A vs scopolamine patches in the treatment of drooling in children with cerebral palsy
- Conditions
- Children with cerebral palsy aged 4 years old and over, presenting a pathological droolingMedDRA version: 20.1Level: PTClassification code 10008129Term: Cerebral palsySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Registration Number
- EUCTR2021-000095-10-FR
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 130
•Aged 4 to 17 years old,
•Cerebral palsy (stable brain injury acquired before the age of 2 years), with disabling drooling,
•Significant impact of drooling on the children (DIS score =40),
•Affiliated or beneficiary of a social security scheme,
•At least one of the parents understanding and speaking French,
•Written consent form signed by both parents
•Absence of known current pregnancy and breastfeeding
Are the trial subjects under 18? yes
Number of subjects for this age range: 130
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
•Previous history of surgery for drooling,
•Injection of botulinum toxin (all locations) in the 3 months prior to the inclusion,
•Treatment by scopolamine patch (Scopoderm®) or other anticholinergic (Artane®, etc.) in the month prior to inclusion,
•Contraindication to the anesthetic or sedation,
•Contraindication to one of the treatments studied (glaucoma, myasthenia, uretroprostatic disorders),
•Injection site infection,
•Swallowing disorder (to saliva) or absence of spontaneous swallowing reflex not investigated by nasoscopy
•On-going or programmed orthodontic treatment over the study period.
•Untreated dental inflammatory condition (dental caries, gingivitis…)
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method